Article information
Full text is only aviable in PDF
References
[1.]
Elsevier, (1985),
[2.]
B.A. Hills.
The Biology of Surfactant.
Cambridge University Press, (1988),
[3.]
F. Possmayer.
Pulmonary perspective: a proposed nomenclature for pulmonary surfactant associated proteins.
Am Rev Respir Dis, 138 (1988),
[4.]
J.A. Wright, R.E. Wager, S. Hawgood, L. Dobbs, J.A. Clements.
Surfactant apoprotein Mr = 26,000-36,000 enhances uptake of liposomes by type II cells.
J Biol Chem, 262 (1987), pp. 2.888-2.894
[5.]
M.E. Avery, J. Mead.
Surface properties in relation to atelectasis and hyaline membrane disease.
Am J Dis Child, 97 (1959), pp. 517-523
[6.]
A. Jobe, M. Ikegami.
Surfactant for the treatment of respiratory distress syndrome.
Am Rev Respir Dis, 136 (1987), pp. 1. 256-1. 275
[7.]
J.F. Lewis, A.H. Jobe.
Surfactant and the adult respiratory distress syndrome.
Am Rev Respir Dis, 147 (1993), pp. 218-233
[8.]
D.A. Hughes, P.L. Haslam.
Effect of smoking on the lipid composition of lung lining fluid and relationship between immunostimulatory lipids, inflammatory cells and foamy macrophages in extrinsic allergic alveolitis.
Eur Respir J, 3 (1990), pp. 1.128-1.139
[9.]
Y. Suzuki, Y. Fujita, K. Kogishi.
Reconstitution of tubular myelin from syntheti lipis and proteins assoiated with pig pulmonary surfactant.
Am Rev Respir Dis, 140 (1989), pp. 75-81
[10.]
A. Takahashi, T. Fujiwara.
Proteolipid in bovine lung surfactant: its role in surfactant function.
Biochem Biophys Res Comm, 135 (1986), pp. 527-532
[11.]
D.G. Ashbaugh, D.B. Bigelow, T.L. Petty, B.E. Levine.
Acute respiratory distress in adults.
Lancet, 2 (1967), pp. 319-323
[12.]
J.E. Weiland, W.B. Davis, J.F. Holter.
Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathological significance.
Am Rev Respir Dis, 133 (1986), pp. 218-225
[13.]
W. Seeger, U. Pison, R. Buchhorn, U. Obertacke, T. Joka.
Surfactant abnormalities and adult respiratory failure.
Lung, 168 (1990), pp. 891-902
[14.]
Haslam PL, Hughes DA, Macnaughton PD, Baker CS, Evans TW. Surfactant replacement therapy in patients with late stage adult respiratory distress syndrome. Lancet 1994. In press.
[15.]
T. Gregory, W. Longmore, M. Moxley, J. Whitsett, C. Reed, A. Fowler, et al.
Surfactant Chemical composition and biophysical activity in acute respiratory distress syndrome.
J Clin Invest, 88 (1991), pp. 1976-1981
[16.]
C. Metz, J. Sibbald.
Anti-inflammatory therapy for acute lung injury. A review of animal and clinical studies.
Chest, 100 (1991), pp. 1110-1119
[17.]
G.U. Meduri, J.M. Belenchia, R.J. Estes, R.G. Wunderink, M.E. Torky, K.V. Leeper Jnr.
Fibroproliferative phase of ARDS Clinical findings and effects of corticosteroids.
Chest, 100 (1991), pp. 943-952
[18.]
Braude S, Haslam PL, Hughes DA, Macnaughton P, Evans T. ‘Chronic’ adult respiratory distress syndrome. A role for corticosteroids? Critical Care Medicine 1992; in press.
[19.]
B.T. Smith, K. Sabry.
Glucocorticoid-thyroid synergism in lung maturation: a mechanism involving epithelial-mesenchymal interaction.
Proc Nat Acad Sci (Wash.), 80 (1983), pp. 1951-1954
[20.]
D.A. Hughes, P.L. Haslam.
Changes in phosphatidylglycerol in bronchoalveolar lavage fluids from patients with cryptogenic fibrosing alveolitis.
Chest, 95 (1989), pp. 82-89
[21.]
P.C. Robinson, L.C. Watters, T.E. King Jr., R.J. Mason.
Idiopathic pulmonary fibrosis: abnormalities in bronchoalveolar lavage phospholipids.
Am Rev Respir Dis, 137 (1988), pp. 585-591
[22.]
R.S. Thrall, C.L. Sendsen, T.H. Shannon, C.A. Kennedy, D.S. Fredrick, M.F. Grunze, S.B. Sulavik.
Correlation of changes in pulmonary surfactant phospholipids with compliance in bleomycin-induced pulmonary fibrosis in the rat.
Am Rev Respir Dis, 136 (1987), pp. 113-118
[23.]
D.F. Liau, C.R. Barrett, A.L.L. Bell, S.F. Ryan.
Normal surface properties of phosphatidylglycerol-deficient surfactant from dog after acute lung injury.
J Lipid Res, 26 (1985), pp. 1338-1344
[24.]
F.X. McCormack, T.E. King Jr., D.R. Voelker, P.C. Robinson, R.J. Mason.
Idiopathic pulmonary fibrosis Abnormalities in the bronchoalveolar lavage content of surfactant protein A1-3.
Am Rev Respir Dis, 144 (1991), pp. 160-166
[25.]
M.J. Ansfield, H.B. Kaltreider, B.J. Benson, J.L. Caldwell.
Immunosuppressive activity of canine pulmonary surface active material.
J Immunol, 122 (1979), pp. 1062-1066
[26.]
M.L. Wilsher, D.A. Hughes, P.L. Haslam.
Immunoregulatory properties of pulmonary surfactant: effect of lung lining fluid on proliferation of human blood lymphocytes.
Thorax, 43 (1988), pp. 354-359
[27.]
M.L. Wilsher, D.A. Hughes, P.L. Haslam.
Immunoregulatory properties of pulmonary surfactant: influence of variations in the phospholipid profile.
Clin Exp Immunol, 73 (1988), pp. 117-122
[28.]
L.W. Schwartz, C.A. Christman.
Lung lining material as a chemoattractant for alveolar macrophages.
Chest, 75 (1979), pp. 284-288
[29.]
R.M. Hoffman, W.D. Claypool, S.L. Katyal, G. Singh, R.M. Rogers, J.H. Dauber.
Augmentation of rat alveolar macrophage migration by surfactant protein.
Am J Respir Dis, 135 (1987), pp. 1358-1362
[30.]
F. van Iwaarden, B. Welmers, J. Verhoef, H.P. Haagsman, L.M. van Golde.
Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages.
Am J Respir Cell Mol Biol, 2 (1990), pp. 91-98
Copyright © 1994. Sociedad Española de Neumología y Cirugía Torácica
